UNSPSC 51422320: Halometasone

This classification denotes a betamethasone analog, anti-asthmatic agent, anti-inflammatory agent, and glucocorticoid with the molecular formula C22H27ClF2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J69Z9UU41Z, chemically known as 2-chloro-6alpha,9-difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione but generally known as halometasone, which bears US NIH Compound Identifier 39745.

UNSPSC 51422320 Halometasone is a Commodity code that nominally describes a specific topical corticosteroid pharmaceutical, yet the recent state and local activity tagged to this code shows a substantial mismatch. Seminole County, Florida solicited naloxone (an opioid antagonist) and drug deactivation systems through an IFB process—neither product falls within the halometasone taxonomy or therapeutic class. The code appears to see minimal relevant recent activity aligned with its stated scope; state and local procurement offices do not currently show active solicitations for halometasone itself under this classification.

Seminole County's IFB60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, represents the sole recent opportunity in the source block and is unrelated to halometasone. The procurement sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs included in vendor proposals. The contract carried a two-year initial term with one-year renewal option, E-Verify and drug-free workplace certification requirements, and potential FEMA funding with associated federal compliance obligations. The mismatch between the code designation and actual procurement suggests either miscategorization by the issuing body or a data-entry error in the opportunity record. Business development professionals should verify the applicable UNSPSC code for halometasone-specific procurement activity before pursuing opportunities under this classification.